Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
The specific drug comes from "GINA (2024)"
The First People's Hospital of Lianyungang
Asthma
1 trial -
Thermal stress and performance without a pre-cooling protocol
Petros Pharmaceuticals
Risk of Heat Stress
1 trial -
Thoracic Paravertebral Block with Local Anesthetic
The First People's Hospital of Lianyungang
Pulmonary Nodules
1 trial -
Ticagrelor monotherapy
The First People's Hospital of Lianyungang
Intracranial Aneurysm
1 trial -
Tirzepatide
United Therapeutics Europe Ltd
Hypertension
1 trial -
Tislelizumab combined with Lenvatinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Initially Unresectable Hepatocellular Carcinoma
1 trial -
To withdraw NSAIDs therapy
The First People's Hospital of Lianyungang
Axial Spondyloarthritis
1 trial -
Tolcapone
United Therapeutics Europe Ltd
Impulsive Behavior
1 trial -
Topical compound tripterygium
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Active Rheumatoid Arthritis
1 trial -
Total glucosides of paeony & Acitretin Capsules
The First People's Hospital of Lianyungang
Psoriasis
1 trial -
Total intravenous anesthesia group
Xuzhou Medical University
Balanced Anesthesia
1 trial -
Treatment
United Therapeutics Europe Ltd
Glucose Metabolism Disorders
1 trial -
Tumour Biopsy and Venous Blood Tests
United Therapeutics Europe Ltd
Soft Tissue Sarcoma
1 trial -
UE
The First People's Hospital of Lianyungang
Lung Cancer
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis (MS) - Relapsing-remitting
1 trial -
Ulinastatin
The First People's Hospital of Lianyungang
Acute Respiratory Distress Syndrome
1 trial -
Ultra low dose chest computed tomography (ULDCT)
Hospital Authority, Hong Kong
Tuberculosis, Pulmonary
1 trial -
Unfractionated heparin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary PCI
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Environmental Exposure
1 trial -
Urinary EDC metabolite testing
Marker Therapeutics
Obesity &Amp;Amp;Amp; Overweight
1 trial -
Urinary kallidinogenase for injection
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Urine Culture
United Therapeutics Europe Ltd
Urinary Tract Infection
1 trial -
Use baby moisturizers by NeoChine
The First People's Hospital of Lianyungang
Neonatal Jaundice
1 trial -
Using medical biological glue for filling And Using the meniscus suture system
The First People's Hospital of Lianyungang
Unilateral Meniscus Tear of the Knee Joint
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources